Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows. The results could have major implications for patients whose cancers carry a mutation in a gene known as EGFR, which is implicated in the out-of-control… read on > read on >
Millions of stray cats roam the world over, and surgical sterilization has long been the primary method of population control. But a small new study shows promising results for a one-and-done contraceptive injection. Researchers say this first-of-its-kind approach appears safe and effective. “A non-surgical contraceptive that could result in lifetime sterility following a single injection… read on > read on >
TUESDAY, June 6, 2023 (American Heart Association News) — As rainbow flags flutter in the June breeze for Pride Month, many LGBTQ+ people will feel tension in the air. “It’s been a really rough go for LGBTQ Americans” of late, said psychiatrist Dr. Natalia Ramos, an assistant clinical professor at the David Geffen School of… read on > read on >
Artificial intelligence (AI) technologies like ChatGPT someday may make a big difference for people seeking answers to questions such as “How can I stop smoking?” They may even offer resources to someone who was sexually assaulted. But they’re not quite there yet, a new study reveals. Researchers wanted to see how well ChatGPT performed for… read on > read on >
A new study on using nitroglycerin patches to help women with frequent hot flashes caused by menopause has delivered mixed results. The benefits of wearing these patches — long used as chest pain medication — were modest. They also were short-lived, with any benefits appearing to wear off over time, according to researchers from the… read on > read on >
Monday can be a downer as folks leave weekend play behind. Now, researchers say Monday might also be the most common day for deadly heart attacks. Doctors at the Belfast Health and Social Care Trust and the Royal College of Surgeons in Ireland determined this by analyzing patient data in Ireland, though they can’t determine… read on > read on >
With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin. The U.S. Food and Drug Administration is working with the Chinese drugmaker Qilu Pharmaceutical to import the widely used cancer drug. The Canadian pharmaceutical company Apotex will… read on > read on >
Women who use estrogen to ease menopause symptoms may see their blood pressure rise — but the way they take the hormone may determine that, a large new study suggests. The study, of over 100,000 menopausal women on estrogen therapy, found that pills seemed to have a greater effect on blood pressure than estrogen delivered… read on > read on >
An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds. The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, according to results presented Sunday at the American Society of Clinical Oncology (ASCO)… read on > read on >
MONDAY, June 5, 2023 (American Heart Association News) — Warmer weather is drawing people outdoors to enjoy nature. But for those who spend time working in the garden or walking along wooded or grassy trails, it also means greater exposure to a menace so tiny they may never even see or feel it. Lyme disease… read on > read on >
-300x181.jpeg)
